Capture Collective was born out of the world-renowned Department of Radiation Oncology at The Ohio State University. Inventor Dr. Jacob and The Ohio State University, teamed up with Ikove Capital, to bring innovative biodosimetry solutions to the market.
Capture has developed technology for a minimally invasive rapid-response testing kit for emergency and first responders (both Civilian and Government) to triage radiation exposure in the event of nuclear leakage or hostile events. This groundbreaking innovation allows for the early detection of radiation toxicity via a rapid, affordable, highly-sensitive, simple blood test.
The patented technology was developed in partnership with The James Cancer Research Institute and the Wexner Medical Center, with millions in funding from the Department of Defense (DoD), the National Institutes of Health (NIH), NASA, and BARDA.